课题基金 / 基金详情

项目摘要

项目成果

MICHAEL Van Doren JOHNSTON的其他基金

相关文献

中文摘要
翻译
在1987-1992年的最初支持期间,神经科学核心是我们MRDDRC的一部分, 由约翰霍普金斯医院的约瑟夫·科伊尔博士指导的突触神经化学单位和脂质组成。 由肯尼迪研究所的岸本康夫博士指导的生物化学单元。突触神经化学的核心 提供神经递质酶的生化分析,高效液相色谱法(HPLC) 包括氨基酸在内的多种神经递质的测定和 大脑中的神经递质受体。脂质生化单位提供了高效液相色谱,气液色谱 (GLC)和用于表征先天性代谢缺陷的GLC-质谱仪测定,包括 神经鞘脂病、过氧化物酶体疾病如肾上腺脑白质营养不良和雷夫苏姆病和溶酶体 紊乱迈克尔约翰斯顿博士取代科伊尔博士担任神经科学核心主任和 突触神经化学单位在下一个时期的支持,从1993年至1998年后,科伊尔博士离开霍普金斯, 成为哈佛医学院精神病学的主席。约翰斯顿医生招募了玛丽布鲁医生作为合作研究者 的sysnaptic神经化学核心开发一个新的神经成像单位的脑组织学。 在此期间,突触神经化学单位继续提供神经递质的HPLC分析 并扩展了用于免疫细胞化学和神经递质分析的先进成像技术 受体和信使RNA的组织切片中使用定量形态测量技术。在同一 当时Paul Watkins博士取代Kishimoto博士担任脂质神经化学核心主任。本单位继续 开发研究过氧化物酶体和相关脂质紊乱和添加气体的先进技术 色谱/质谱服务,用于研究脂肪和有机酸紊乱, 理查德·凯利博士神经科学核心的领导地位在另外两个时期保持稳定, 1998-2008年的支持。核心继续为神经科学提供最现代的技术 研究,包括HPLC设备,几个用于计算机形态测定和体视学的系统, 最近增加了共聚焦显微镜系统。脂质生物化学中心的设备也 已更新,以提供对过氧化物酶体和有机酸紊乱的扩展研究。
英文摘要
The Neuroscience Core was a part of our MRDDRC during the initial period of support from 1987-1992, and consisted of a synaptic neurochemistry unit directed by Dr. Joseph Coyle at Johns Hopkins Hospital and a lipid biochemistry unit directed by Dr. Yasuo Kishimoto at the Kennedy Institute. The synaptic neurochemistry core provided biochemical assays for neurotransmitter enzymes, high performance liquid chromatography (HPLC) assays for a variety of neurotransmitters including amino acids and receptor binding assays for neurotransmitter receptors in the brain. The lipid biochemistry unit provided HPLC, gas liquid chromatography (GLC) and GLC-mass spectrometer assays used to characterize inborn errors of metabolism including sphingolipidoses, peroxisomal disorders such as adrenoleukodystrophy and Refsum's disease and lysosomal disorders. Dr. Michael Johnston replaced Dr. Coyle as director of the Neuroscience Core and head of the synaptic neurochemistry unit during the next period of support from 1993-1998 after Dr. Coyle left Hopkins to become the chairman of psychiatry at Harvard Medical School. Dr. Johnston recruited Dr. Mary Blue as a coinvestigator of the sysnaptic neurochemistry core to develop a new neuroimaging unit for brain histology. During this period the synaptic neurochemistry unit continued to provide HPLC assays for neurotransmitters and expanded sophisticated imaging techniques for immunocytochemistry and analysis of neurotransmitter receptors and messenger RNA's in tissue sections using quantitative morphometric techniques. At the same time Dr. Paul Watkins replaced Dr. Kishimoto as director of the lipid neurochemistry core. This unit continued to develop advanced techniques for studying peroxisomal and related lipid disorders and added gas chromatography/mass spectrometry services for studying fatty and organic acid disorders under the direction of Dr. Richard Kelley. Leadership of the Neuroscience Core has remained stable for two additional periods of support from 1998-2008. The Core has continues to provide the most modern technology for neuroscience research including HPLC equipment, several systems for computerized morphometry and stereology, and most recently has added a confocal microscope system. Equipment in the lipid biochemistry core has also been updated to provide expanded research on peroxisomal and organic acid disorders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Child Neurologist Career Development Program (CNCDP)
Child Neurologist Career Development Program (CNCDP)
Clinical Translational Core
NEUROBIOLOGY